Decreased levels of cystatin C, an inhibitor of the elastolytic enzyme cysteine protease, in acute and subacute phases of Kawasaki disease

Cardiology

Volumn 99, Issue 3, 2003, Pages 121-125

  Gupta Malhotra, Monesha ^a,c,d   Levine, Daniel M ^b   Cooper, Rubin S ^c   Zabriskie, John B ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b ROGOSIN INSTITUTE   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Aneurysm; Cystatin C; Cysteine protease inhibitor; Kawasaki disease

Indexed keywords

CYSTATIN C; CYSTEINE PROTEINASE INHIBITOR;

ACUTE DISEASE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ELASTOLYSIS; FEMALE; HUMAN; IMMUNOTHERAPY; INFANT; INFECTION; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COHORT STUDIES; CYSTATINS; CYSTEINE ENDOPEPTIDASES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0037971019     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070668     Document Type: Article

References (26)

1. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF: The prevention of coronary aneurysm in Kawasaki disease: A meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995;96:1057-1061.
2. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, Sasaki N, Asano H, Kyo S, Yokote Y: Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation 2001;104:860-863.
3. Vine N, Powell JT: Metalloproteinases in degenerative aortic disease. Clin Sci 1991;81:233-239.
4. Powell J, Greenhalgh RM: Cellular, enzymatic, and genetic factors in the pathogenesis of abdominal aortic aneurysms. J Vasc Surg 1989;9:297-304.
5. Knox JB, Sukhova GK, Whittemore AD, Libby P: Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 1997;95:205-212.
6. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT: Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995;15:1145-1151.
7. Herron GS, Unemori E, Wong M, Rapp JH, Hibbs MH, Stoney RJ: Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Arteriosclerosis 1991;11:1667-1677.
8. Galis ZS, Muszynski M, Sukhova G, Simon-Morrissey E, Unemori EN, Lark MW: Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994;75:181-189.
9. Barrett AJ, Davies ME, Grubb A: The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Bio-phys Res Commun 1984;120:631-636.
10. Shi G-P, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, Ridker PM, Libby P, Chapman HA: Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999;104:1191-1197.
11. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa S: A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54:271-276.
12. Ishiguro H, Ohkubo I, Mizokami M, Titani K, Sasaki M: The use of monoclonal antibodies to define levels of cystatin C in normal human serum. Hybridoma 1989;8:303-313.
13. Harmoinen A, Ylinen E, Ala-Houhala M, Janas M, Kaila M, Kouri T: Reference intervals for cystatin C in pre- and full-term infants and children. Pediatr Nephrol 2000;15:105-108.
14. Naoe S, Shibuya K, Takahashi K, Wakayama M, Masuda H, Tanaka M: Pathologic observations concerning the cardiovascular lesions in Kawasaki disease. Cardiol Young 1991;1:212-220.
15. Masuda H, Shozawa T, Naoe S, Tanaka N: The intercostal artery in Kawasaki disease: A pathologic study of 17 autopsy cases. Arch Pathol Lab Med 1986;110:1136-1142.
16. Fujiwara H, Hamashima Y: Pathology of the heart in Kawasaki disease. Pediatrics 1978;61:100-107.
17. Masuda H, Naoe S, Tanaka N: A pathological study of coronary artery in Kawasaki disease (MCLS) with special reference to morphogenesis of aneurysm. J Jpn Coll Angiol 1981;21:899-912.
18. Cohen JR, Sarfati I, Danna D, Wise L: Smooth muscle cell elastase, atherosclerosis, and abdominal aortic aneurysms. Ann Surg 1992;216:327-330.
19. Cohen JR, Faust G, Tenenbaum N, Sarfati I, Rogowsky P, Wise L: The calcium messenger system and the kinetics of elastase release from human neutrophils in patients with abdominal aortic aneurysms. Ann Vasc Surg 1990;4:570-574.
20. Abrahamson M, Islam MQ, Szpirer J, Szpirer C, Levan G: The human cystatin C gene (CST3), mutated in hereditary cystatin C amyloid angiopathy, is located on chromosome 20. Hum Genet 1989;82:223-226.
21. Jensson O, Gudmundsson G, Arnason A, Blondal H, Petursdottir I, Thorsteinsson L, Grubb A, Lofberg H, Cohen D, Frangione B: Hereditary cystatin C (γ trace) amyloid angiopathy of the CNS causing cerebral hemorrhage. Acta Neurol Scand 1987;76:102-114.
22. Ghiso J, Jensson O, Frangione B: Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of γ trace basic protein (cystatin C). Proc Natl Acad Sci USA 1986;83:2974-2978.
23. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP: Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995;47:312-318.
24. Matsubara T, Umezawa Y, Tsuru S, Motohashi T, Yabuta K, Furukawa S: Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease. Scand J Rheumatol 1997;26:314-317.
25. Shukhova GK, Shi G-P, Simon DI, Chapman HA, Libby P: Expression of elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998;102:576-583.
26. Gupta M, Noel GJ, Schaefer M, Friedman DM, Bussel JB, Johann-Liang R: Cytokine modulation with immune γ-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. J Clin Immunol 2001;21:208-214.